SUGAR RONALD D, Director, subtracted 2,000 shares of Amgen Inc. (AMGN) from its portfolio at the rate of $187.58 per share valuing $375,160 on Jul 03. The insider left behind 14,336 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Amgen Inc. (AMGN) was $178.00. Currently, the 1st Resistance Point for this stock is $180.68, with a 2nd Resistance Point sitting at $183.37. Meanwhile, this company’s stock has a 1st Support Level at $175.63 and a 2nd Support Level at $173.27. Amgen Inc. (AMGN) stock has lost -$10.58, or -5.61%, in the past five days. In the last full month, these shares have gained $3.38, or 1.94%. In the past three months, this stock’s price has fallen by -$14.11, or -7.34%. This year-to-date, Amgen Inc. (AMGN) shares have lost -$16.67, or -8.56%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Amgen Inc. (AMGN) stock, 40% of short-term indicators suggest that these shares are a “ Hold .” Meanwhile, 25% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 67% of long-term indicators suggest that this stock is a “ Sell .”
With 609,936 K shares outstanding, this company currently has a market capitalization of $108,568,600K. Amgen Inc. (AMGN) generates $23,747 M in annual sales, amounting to annual net income of $8,394 M. This stock has generated a 1-Year Total Return of -7.84%, a 3-Year Total Return of 9.02%, and a 5-year Total Return of 50.46%. This stock’s 5-Year Dividend Growth is 180.85%, with its most recent dividend valued at $1.450 per share on 05/16/19. Its Annual Dividend Yield is 3.18%, and its Annual Dividend Rate is 5.80.
In the most recently-reported fiscal quarter, which ended in Mar-19, Amgen Inc. (AMGN) reported earnings of $3.56 per share. Wall Street analysts, on average, were expecting the company to report earnings of $3.48 per share, representing a 0.08 difference and 2.40% surprise. In the previous quarter ending in Dec-18, the reported earnings of $3.42 represented a 0.15 difference from the consensus estimate calling for $3.27 per share, which was a 4.49% surprise.
For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is $3.59 per share. This estimate came from a total of 10 Wall Street Analysts. Of those market experts, the high estimate was $3.80 and the low estimate was $3.33. In the year-ago quarter, Amgen Inc. (AMGN) generated per-share earnings of $3.83. If the analysts are correct about the current quarter’s earnings, the growth will be -6.27% .
Turning our focus now to insider trading activity, there have been 24 purchases (60,851 shares in total) and 19 sale (16,407 shares in total) in the last 3 months. In the last 6 months, there have been 36 insider buys amounting to 159,061 shares and 32 insider sales amounting to 30,412 shares. In the past full year, 47 insider purchases were made (involving 238,542 shares) and 41 insider sell-offs equivalent to 79,950 shares.
Moving onto liquidity, Amgen Inc. (AMGN) has a Current Ratio of 2.79, a Quick Ratio of 2.57 and a Cash Ratio of 2.17. Looking at this company’s capital structure, its Total Debt to Total Equity is 271.43, its Total Debt to Total Capital is 73.08, and its Total Debt to Total Assets is now 51.09. Looking even further ahead into the future, its Long-Term Debt to Equity is 236.08 and its Long-Term Debt to Total Capital is 63.56.